Cryptococcosis Treatment Market: Analysis and Forecast

Cryptococcosis Treatment Market by Type and Application – Global Market Size Estimation, Industry‑Wide Analysis, Competitive Landscape Assessment & Long‑Term Forecast to 2032

4.2%

CAGR (2026-2032)

6.26 USD Bn.

Market Size

318

Report Pages

132

Market Tables

Overview

The Cryptococcosis Treatment Market size was valued at USD 6.26 Billion in 2025 and the total Cryptococcosis Treatment revenue is expected to grow at a CAGR of 4.2% from 2025 to 2032, reaching nearly USD 8.34 Billion by 2032.

Cryptococcosis is a fungal disease. It is an infection caused by inhaling the fungus caused either by Cryptococcus neoformans or Cryptococcus gattii. The disease is spread through breathing of fungus related to bird species. The fungus mostly affects the lungs, but it has the potential to spread to the brain, called meningitis. The symptoms of the disease such as dry cough, fever, headache, blurred vision and fatigue. Cryptococcosis can be treated by giving dozes of amphotericin B, flucytosine and fluconazole.
To know about the Research Methodology:- Request Free Sample Report

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Cryptococcosis Treatment Market Drivers and Restrains

Rise in occurrence of fatal fungal disease, last-stage HIV patients developing the disease and availability of advanced treatment options are driving the growth of Cryptococcosis market globally. The increasing number of HIV patients are providing an up thrust to the market. According to recent study, it has been found that the death of xx % of HIV patients is because of improper treatment of cryptococcosis. HIV patients are immunocompromised and have a weak immune system, thus making an easy entry into the body for such fungus.

In developing countries, people are not diagnosed early due to a lack of diagnostic tests, therefore affecting the Cryptococcosis Treatment market. According to Centers for Disease Control and Prevention states that around X million cryptococcosis cases rise throughout the world, and it is expected that annually, the number of deaths associated with cryptococcosis is around xx thousand. Eliminate the disease and the advancement in diagnosis and treatment is driving the market.

Manufacturers in the Cryptococcosis Treatment are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

Segmentation Analysis

The Cryptococcosis Treatment market is segmented based on treatment type, application and regionally. The global cryptococcosis market is segmented on the basis of treatment type, mainly into Amphotericin B, Flucytosine and Fluconazole. The Amphotericin B further sub segmented into Amphocin, Fungizone, and other products. Flucytosine is further segmented into Ancobon and other products. Flucytosine used for serious Candida infections and cryptococcosis. Fluconazole includes Diflucan and other products. In terms of treatment type, Flucytosine was the leading segment in the cryptococcosis treatment market in terms of revenue for 2025, driven by its large scale adoption in the North America region. The cryptococcosis Treatment market in the Africa and Middle East is expected to expand at a substantial growth rate because of the contribution of Sub-Sahara African countries in terms of request, where the count of HIV patients is remarkably high.

The North America and the Middle East and Africa are projected to be highly profitable regions in the cryptococcosis treatment market. While Europe, Asia Pacific, and Latin America expected to remain relatively smaller in terms of demand and growth rate. Based on the application, the cryptococcosis treatment market is segmented into hospital pharmacies, retail pharmacies, drug store, and mail order pharmacies. Retail pharmacy was the leading segment in the global market on the basis of profits, for 2025.

This segment is also predictable to continue dominating the market till 2032, because of growing contribution of long-term medication needed for successful cryptococcosis treatment. Online purchase of drugs has been highly popular in a lot of developed economies such as United State and Japan. Online pharmaceutical sellers are also generating high volume of preference in developing economies including Brazil, China, and India. Furthermore, increasing the scope of growth for the global cryptococcosis treatment market during the forecast period. Based on region, it is studied across Asia Pacific, North America, Europe, Latin America and Middle East Africa.

Regional Analysis

On the basis of region Cryptococcosis Treatment Market divided into five region such as Asia Pacific, North America, Europe, Latin America, and Middle East Africa. Among all the regions, North America had hold the largest market share in 2018 and is projected to lead the market during the forecast period. Because of the increasing prevalence of the infection in prevalent areas of the United State, coupled with a higher penetration of healthcare services across the country. The region is expected to continue to lead the global cryptococcosis market till 2032, a statistic attributed to the rising numbers of the HIV infected population in the region. Furthermore, highly structured and advanced healthcare industry, and well-defined repayment policies from public as well as private health insurance firms. Asia Pacific is expected to be the second largest market over the forecast period and nearly follow by North America in terms of profits.

The objective of the report is to present comprehensive analysis of Cryptococcosis Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Cryptococcosis Treatment Market dynamics, structure by analyzing the market segments, and project the Cryptococcosis Treatment Market size. Clear representation of competitive analysis of key players by Cryptococcosis Treatment Type, price, financial position, product portfolio, growth strategies, and regional presence in the Cryptococcosis Treatment Market make the report investor’s guide.

Cryptococcosis Treatment Market Scope : Inquire before buying

Global Cryptococcosis Treatment Market
Report Coverage	Details
Base Year:	2025	Forecast Period:	2026-2032
Historical Data:	2020 to 2025	Market Size in 2025:	USD 6.26 Bn.
Forecast Period 2026 to 2032 CAGR:	4.2%	Market Size in 2032:	USD 8.34 Bn.
Segments Covered:	by Type	Amphotericin B Flucytosine Fluconazole Others
Segments Covered:	by Application	Hospital Pharmacies Retail Pharmacies Drug Store Others

Cryptococcosis Treatment Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Cryptococcosis Treatment Market, Major Players

1. Bristol-Myers Squibb Company
2. Sigmapharm Laboratories LLC
3. Janssen Biotech
4. Novartis AG
5. Abbott Laboratories
6. Valeant Pharmaceuticals Inc.
7. Glenmark Pharmaceuticals.
8. ECR Pharmaceuticals
9. Eisai Co.
10. Flynn Pharma
11. Johnson and Johnson
12. Meda Consumer Healthcare Inc.
13. Merck and Co. Inc.
14. Neurim
15. Pernix Therapeutics
16. Pfizer Inc
17. Purdue Pharma L.P.
18. Sanofi Pasteur
19. SkyePharma
20. Takeda Pharmaceutical Company
21. Astellas Pharma Inc.
22. Bausch Health Companies Inc.
23. Matinas BioPharma
24. Teva Pharmaceutical Industries Ltd.
25. Viamet Pharmaceuticals,Inc

Frequently Asked Questions:

1. Which region has the largest share in Global Cryptococcosis Treatment market?
Ans: Asia Pacific region holds the highest share in 2025.

2. What is the growth rate of Global Cryptococcosis Treatment market?
Ans: The Global market is growing at a CAGR of 4.2% during forecasting period 2026-2032.

3. What is scope of the Global Cryptococcosis Treatment market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. What is the study period of this market?
Ans: The Global market is studied from 2025 to 2032.

Cryptococcosis Treatment Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Cryptococcosis Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Cryptococcosis Treatment Market Analysis and Forecast 6.1. Global Cryptococcosis Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Cryptococcosis Treatment Market Analysis and Forecast, by Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Cryptococcosis Treatment Market Value Share Analysis, by Type 7.4. Global Cryptococcosis Treatment Market Size (US$ Bn) Forecast, by Type 7.5. Global Cryptococcosis Treatment Market Analysis, by Type 7.6. Global Cryptococcosis Treatment Market Attractiveness Analysis, by Type 8. Global Cryptococcosis Treatment Market Analysis and Forecast, by Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Cryptococcosis Treatment Market Value Share Analysis, by Application 8.4. Global Cryptococcosis Treatment Market Size (US$ Bn) Forecast, by Application 8.5. Global Cryptococcosis Treatment Market Analysis, by Application 8.6. Global Cryptococcosis Treatment Market Attractiveness Analysis, by Application 9. Global Cryptococcosis Treatment Market Analysis, by Region 9.1. Global Cryptococcosis Treatment Market Value Share Analysis, by Region 9.2. Global Cryptococcosis Treatment Market Size (US$ Bn) Forecast, by Region 9.3. Global Cryptococcosis Treatment Market Attractiveness Analysis, by Region 10. North America Cryptococcosis Treatment Market Analysis 10.1. Key Findings 10.2. North America Cryptococcosis Treatment Market Overview 10.3. North America Cryptococcosis Treatment Market Value Share Analysis, by Type 10.4. North America Cryptococcosis Treatment Market Forecast, by Type 10.4.1. Amphotericin B 10.4.2. Flucytosine 10.4.3. Fluconazole 10.4.4. Others 10.5. North America Cryptococcosis Treatment Market Value Share Analysis, by Application 10.6. North America Cryptococcosis Treatment Market Forecast, by Application 10.6.1. Hospital Pharmacies 10.6.2. Retail Pharmacies 10.6.3. Drug Store 10.6.4. Others 10.7. North America Cryptococcosis Treatment Market Value Share Analysis, by Country 10.8. North America Cryptococcosis Treatment Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Cryptococcosis Treatment Market Analysis, by Country 10.10. U.S. Cryptococcosis Treatment Market Forecast, by Type 10.10.1. Amphotericin B 10.10.2. Flucytosine 10.10.3. Fluconazole 10.10.4. Others 10.11. U.S. Cryptococcosis Treatment Market Forecast, by Application 10.11.1. Hospital Pharmacies 10.11.2. Retail Pharmacies 10.11.3. Drug Store 10.11.4. Others 10.12. Canada Cryptococcosis Treatment Market Forecast, by Type 10.12.1. Amphotericin B 10.12.2. Flucytosine 10.12.3. Fluconazole 10.12.4. Others 10.13. Canada Cryptococcosis Treatment Market Forecast, by Application 10.13.1. Hospital Pharmacies 10.13.2. Retail Pharmacies 10.13.3. Drug Store 10.13.4. Others 10.14. North America Cryptococcosis Treatment Market Attractiveness Analysis 10.14.1. By Type 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Cryptococcosis Treatment Market Analysis 11.1. Key Findings 11.2. Europe Cryptococcosis Treatment Market Overview 11.3. Europe Cryptococcosis Treatment Market Value Share Analysis, by Type 11.4. Europe Cryptococcosis Treatment Market Forecast, by Type 11.4.1. Amphotericin B 11.4.2. Flucytosine 11.4.3. Fluconazole 11.4.4. Others 11.5. Europe Cryptococcosis Treatment Market Value Share Analysis, by Application 11.6. Europe Cryptococcosis Treatment Market Forecast, by Application 11.6.1. Hospital Pharmacies 11.6.2. Retail Pharmacies 11.6.3. Drug Store 11.6.4. Others 11.7. Europe Cryptococcosis Treatment Market Value Share Analysis, by Country 11.8. Europe Cryptococcosis Treatment Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Cryptococcosis Treatment Market Analysis, by Country 11.10. Germany Cryptococcosis Treatment Market Forecast, by Type 11.10.1. Amphotericin B 11.10.2. Flucytosine 11.10.3. Fluconazole 11.10.4. Others 11.11. Germany Cryptococcosis Treatment Market Forecast, by Application 11.11.1. Hospital Pharmacies 11.11.2. Retail Pharmacies 11.11.3. Drug Store 11.11.4. Others 11.12. U.K. Cryptococcosis Treatment Market Forecast, by Type 11.12.1. Amphotericin B 11.12.2. Flucytosine 11.12.3. Fluconazole 11.12.4. Others 11.13. U.K. Cryptococcosis Treatment Market Forecast, by Application 11.13.1. Hospital Pharmacies 11.13.2. Retail Pharmacies 11.13.3. Drug Store 11.13.4. Others 11.14. France Cryptococcosis Treatment Market Forecast, by Type 11.14.1. Amphotericin B 11.14.2. Flucytosine 11.14.3. Fluconazole 11.14.4. Others 11.15. France Cryptococcosis Treatment Market Forecast, by Application 11.15.1. Hospital Pharmacies 11.15.2. Retail Pharmacies 11.15.3. Drug Store 11.15.4. Others 11.16. Italy Cryptococcosis Treatment Market Forecast, by Type 11.16.1. Amphotericin B 11.16.2. Flucytosine 11.16.3. Fluconazole 11.16.4. Others 11.17. Italy Cryptococcosis Treatment Market Forecast, by Application 11.17.1. Hospital Pharmacies 11.17.2. Retail Pharmacies 11.17.3. Drug Store 11.17.4. Others 11.18. Spain Cryptococcosis Treatment Market Forecast, by Type 11.18.1. Amphotericin B 11.18.2. Flucytosine 11.18.3. Fluconazole 11.18.4. Others 11.19. Spain Cryptococcosis Treatment Market Forecast, by Application 11.19.1. Hospital Pharmacies 11.19.2. Retail Pharmacies 11.19.3. Drug Store 11.19.4. Others 11.20. Rest of Europe Cryptococcosis Treatment Market Forecast, by Type 11.20.1. Amphotericin B 11.20.2. Flucytosine 11.20.3. Fluconazole 11.20.4. Others 11.21. Rest of Europe Cryptococcosis Treatment Market Forecast, by Application 11.21.1. Hospital Pharmacies 11.21.2. Retail Pharmacies 11.21.3. Drug Store 11.21.4. Others 11.22. Europe Cryptococcosis Treatment Market Attractiveness Analysis 11.22.1. By Type 11.22.2. By Application 11.23. PEST Analysis 11.24. Key Trend 11.25. Key Development 12. Asia Pacific Cryptococcosis Treatment Market Analysis 12.1. Key Findings 12.2. Asia Pacific Cryptococcosis Treatment Market Overview 12.3. Asia Pacific Cryptococcosis Treatment Market Value Share Analysis, by Type 12.4. Asia Pacific Cryptococcosis Treatment Market Forecast, by Type 12.4.1. Amphotericin B 12.4.2. Flucytosine 12.4.3. Fluconazole 12.4.4. Others 12.5. Asia Pacific Cryptococcosis Treatment Market Value Share Analysis, by Application 12.6. Asia Pacific Cryptococcosis Treatment Market Forecast, by Application 12.6.1. Hospital Pharmacies 12.6.2. Retail Pharmacies 12.6.3. Drug Store 12.6.4. Others 12.7. Asia Pacific Cryptococcosis Treatment Market Value Share Analysis, by Country 12.8. Asia Pacific Cryptococcosis Treatment Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Cryptococcosis Treatment Market Analysis, by Country 12.10. China Cryptococcosis Treatment Market Forecast, by Type 12.10.1. Amphotericin B 12.10.2. Flucytosine 12.10.3. Fluconazole 12.10.4. Others 12.11. China Cryptococcosis Treatment Market Forecast, by Application 12.11.1. Hospital Pharmacies 12.11.2. Retail Pharmacies 12.11.3. Drug Store 12.11.4. Others 12.12. India Cryptococcosis Treatment Market Forecast, by Type 12.12.1. Amphotericin B 12.12.2. Flucytosine 12.12.3. Fluconazole 12.12.4. Others 12.13. India Cryptococcosis Treatment Market Forecast, by Application 12.13.1. Hospital Pharmacies 12.13.2. Retail Pharmacies 12.13.3. Drug Store 12.13.4. Others 12.14. Japan Cryptococcosis Treatment Market Forecast, by Type 12.14.1. Amphotericin B 12.14.2. Flucytosine 12.14.3. Fluconazole 12.14.4. Others 12.15. Japan Cryptococcosis Treatment Market Forecast, by Application 12.15.1. Hospital Pharmacies 12.15.2. Retail Pharmacies 12.15.3. Drug Store 12.15.4. Others 12.16. ASEAN Cryptococcosis Treatment Market Forecast, by Type 12.16.1. Amphotericin B 12.16.2. Flucytosine 12.16.3. Fluconazole 12.16.4. Others 12.17. ASEAN Cryptococcosis Treatment Market Forecast, by Application 12.17.1. Hospital Pharmacies 12.17.2. Retail Pharmacies 12.17.3. Drug Store 12.17.4. Others 12.18. Rest of Asia Pacific Cryptococcosis Treatment Market Forecast, by Type 12.18.1. Amphotericin B 12.18.2. Flucytosine 12.18.3. Fluconazole 12.18.4. Others 12.19. Rest of Asia Pacific Cryptococcosis Treatment Market Forecast, by Application 12.19.1. Hospital Pharmacies 12.19.2. Retail Pharmacies 12.19.3. Drug Store 12.19.4. Others 12.20. Asia Pacific Cryptococcosis Treatment Market Attractiveness Analysis 12.20.1. By Type 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Cryptococcosis Treatment Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Cryptococcosis Treatment Market Overview 13.3. Middle East & Africa Cryptococcosis Treatment Market Value Share Analysis, by Type 13.4. Middle East & Africa Cryptococcosis Treatment Market Forecast, by Type 13.4.1. Amphotericin B 13.4.2. Flucytosine 13.4.3. Fluconazole 13.4.4. Others 13.5. Middle East & Africa Cryptococcosis Treatment Market Value Share Analysis, by Application 13.6. Middle East & Africa Cryptococcosis Treatment Market Forecast, by Application 13.6.1. Hospital Pharmacies 13.6.2. Retail Pharmacies 13.6.3. Drug Store 13.6.4. Others 13.7. Middle East & Africa Cryptococcosis Treatment Market Value Share Analysis, by Country 13.8. Middle East & Africa Cryptococcosis Treatment Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Cryptococcosis Treatment Market Analysis, by Country 13.10. GCC Cryptococcosis Treatment Market Forecast, by Type 13.10.1. Amphotericin B 13.10.2. Flucytosine 13.10.3. Fluconazole 13.10.4. Others 13.11. GCC Cryptococcosis Treatment Market Forecast, by Application 13.11.1. Hospital Pharmacies 13.11.2. Retail Pharmacies 13.11.3. Drug Store 13.11.4. Others 13.12. South Africa Cryptococcosis Treatment Market Forecast, by Type 13.12.1. Amphotericin B 13.12.2. Flucytosine 13.12.3. Fluconazole 13.12.4. Others 13.13. South Africa Cryptococcosis Treatment Market Forecast, by Application 13.13.1. Hospital Pharmacies 13.13.2. Retail Pharmacies 13.13.3. Drug Store 13.13.4. Others 13.14. Rest of Middle East & Africa Cryptococcosis Treatment Market Forecast, by Type 13.14.1. Amphotericin B 13.14.2. Flucytosine 13.14.3. Fluconazole 13.14.4. Others 13.15. Rest of Middle East & Africa Cryptococcosis Treatment Market Forecast, by Application 13.15.1. Hospital Pharmacies 13.15.2. Retail Pharmacies 13.15.3. Drug Store 13.15.4. Others 13.16. Middle East & Africa Cryptococcosis Treatment Market Attractiveness Analysis 13.16.1. By Type 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Cryptococcosis Treatment Market Analysis 14.1. Key Findings 14.2. South America Cryptococcosis Treatment Market Overview 14.3. South America Cryptococcosis Treatment Market Value Share Analysis, by Type 14.4. South America Cryptococcosis Treatment Market Forecast, by Type 14.4.1. Amphotericin B 14.4.2. Flucytosine 14.4.3. Fluconazole 14.4.4. Others 14.5. Others South America Cryptococcosis Treatment Market Value Share Analysis, by Application 14.6. South America Cryptococcosis Treatment Market Forecast, by Application 14.6.1. Hospital Pharmacies 14.6.2. Retail Pharmacies 14.6.3. Drug Store 14.6.4. Others 14.7. South America Cryptococcosis Treatment Market Value Share Analysis, by Country 14.8. South America Cryptococcosis Treatment Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Cryptococcosis Treatment Market Forecast, by Type 14.9.1. Amphotericin B 14.9.2. Flucytosine 14.9.3. Fluconazole 14.9.4. Others 14.10. Brazil Cryptococcosis Treatment Market Forecast, by Application 14.10.1. Hospital Pharmacies 14.10.2. Retail Pharmacies 14.10.3. Drug Store 14.10.4. Others 14.11. Mexico Cryptococcosis Treatment Market Forecast, by Type 14.11.1. Amphotericin B 14.11.2. Flucytosine 14.11.3. Fluconazole 14.11.4. Others 14.12. Mexico Cryptococcosis Treatment Market Forecast, by Application 14.12.1. Hospital Pharmacies 14.12.2. Retail Pharmacies 14.12.3. Drug Store 14.12.4. Others 14.13. Rest of South America Cryptococcosis Treatment Market Forecast, by Type 14.13.1. Amphotericin B 14.13.2. Flucytosine 14.13.3. Fluconazole 14.13.4. Others 14.14. Rest of South America Cryptococcosis Treatment Market Forecast, by Application 14.14.1. Hospital Pharmacies 14.14.2. Retail Pharmacies 14.14.3. Drug Store 14.14.4. Others 14.15. South America Cryptococcosis Treatment Market Attractiveness Analysis 14.15.1. By Type 14.15.2. By Application 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.3.1. M&A by Regions, Investment and Applications 15.2.3.2. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Bristol-Myers Squibb Company 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. Sigmapharm Laboratories LLC 15.3.3. Janssen Biotech 15.3.4. Novartis AG 15.3.5. Abbott Laboratories 15.3.6. Valeant Pharmaceuticals Inc. 15.3.7. Glenmark Pharmaceuticals. 15.3.8. ECR Pharmaceuticals 15.3.9. Eisai Co. 15.3.10. Flynn Pharma 15.3.11. Johnson and Johnson 15.3.12. Meda Consumer Healthcare Inc. 15.3.13. Merck and Co. Inc. 15.3.14. Neurim 15.3.15. Pernix Therapeutics 15.3.16. Pfizer Inc 15.3.17. Purdue Pharma L.P. 15.3.18. Sanofi Pasteur 15.3.19. SkyePharma 15.3.20. Takeda Pharmaceutical Company 15.3.21. Astellas Pharma Inc. 15.3.22. Bausch Health Companies Inc. 15.3.23. Matinas BioPharma 15.3.24. Teva Pharmaceutical Industries Ltd. 15.3.25. Viamet Pharmaceuticals,Inc 16. Primary Key Insights

Cryptococcosis Treatment Market

Choose License Type